233 related articles for article (PubMed ID: 8411353)
41. Mutation in the glycosylated gag protein of murine leukemia virus results in reduced in vivo infectivity and a novel defect in viral budding or release.
Low A; Datta S; Kuznetsov Y; Jahid S; Kothari N; McPherson A; Fan H
J Virol; 2007 Apr; 81(8):3685-92. PubMed ID: 17267509
[TBL] [Abstract][Full Text] [Related]
42. Ubiquitination of HIV-1 and MuLV Gag.
Ott DE; Coren LV; Chertova EN; Gagliardi TD; Schubert U
Virology; 2000 Dec; 278(1):111-21. PubMed ID: 11112487
[TBL] [Abstract][Full Text] [Related]
43. In vitro selection of RNAs that bind to the human immunodeficiency virus type-1 gag polyprotein.
Lochrie MA; Waugh S; Pratt DG; Clever J; Parslow TG; Polisky B
Nucleic Acids Res; 1997 Jul; 25(14):2902-10. PubMed ID: 9207041
[TBL] [Abstract][Full Text] [Related]
44. Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication.
Lee SK; Nagashima K; Hu WS
J Virol; 2005 Apr; 79(7):4159-69. PubMed ID: 15767417
[TBL] [Abstract][Full Text] [Related]
45. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity.
Kräusslich HG; Fäcke M; Heuser AM; Konvalinka J; Zentgraf H
J Virol; 1995 Jun; 69(6):3407-19. PubMed ID: 7745687
[TBL] [Abstract][Full Text] [Related]
46. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
Fitzon T; Leschonsky B; Bieler K; Paulus C; Schröder J; Wolf H; Wagner R
Virology; 2000 Mar; 268(2):294-307. PubMed ID: 10704338
[TBL] [Abstract][Full Text] [Related]
47. Analytical study of rat retrotransposon VL30 RNA dimerization in vitro and packaging in murine leukemia virus.
Torrent C; Bordet T; Darlix JL
J Mol Biol; 1994 Jul; 240(5):434-44. PubMed ID: 8046749
[TBL] [Abstract][Full Text] [Related]
48. Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway.
Chazal N; Gay B; Carrière C; Tournier J; Boulanger P
J Virol; 1995 Jan; 69(1):365-75. PubMed ID: 7983731
[TBL] [Abstract][Full Text] [Related]
49. Mutagenesis of N-terminal residues of feline foamy virus Gag reveals entirely distinct functions during capsid formation, particle assembly, Gag processing and budding.
Liu Y; Betts MJ; Lei J; Wei G; Bao Q; Kehl T; Russell RB; Löchelt M
Retrovirology; 2016 Aug; 13(1):57. PubMed ID: 27549192
[TBL] [Abstract][Full Text] [Related]
50. Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor.
Yuan X; Yu X; Lee TH; Essex M
J Virol; 1993 Nov; 67(11):6387-94. PubMed ID: 8411340
[TBL] [Abstract][Full Text] [Related]
51. Matrix protein of Akv murine leukemia virus: genetic mapping of regions essential for particle formation.
Jørgensen EC; Pedersen FS; Jørgensen P
J Virol; 1992 Jul; 66(7):4479-87. PubMed ID: 1318415
[TBL] [Abstract][Full Text] [Related]
52. Identification of a cytoplasmic targeting/retention signal in a retroviral Gag polyprotein.
Choi G; Park S; Choi B; Hong S; Lee J; Hunter E; Rhee SS
J Virol; 1999 Jul; 73(7):5431-7. PubMed ID: 10364290
[TBL] [Abstract][Full Text] [Related]
53. Structural interactions between retroviral Gag proteins examined by cysteine cross-linking.
Hansen MS; Barklis E
J Virol; 1995 Feb; 69(2):1150-9. PubMed ID: 7815493
[TBL] [Abstract][Full Text] [Related]
54. A bipartite membrane-binding signal in the human immunodeficiency virus type 1 matrix protein is required for the proteolytic processing of Gag precursors in a cell type-dependent manner.
Lee YM; Tian CJ; Yu XF
J Virol; 1998 Nov; 72(11):9061-8. PubMed ID: 9765451
[TBL] [Abstract][Full Text] [Related]
55. HIV-1 gag proteins: diverse functions in the virus life cycle.
Freed EO
Virology; 1998 Nov; 251(1):1-15. PubMed ID: 9813197
[TBL] [Abstract][Full Text] [Related]
56. The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein.
Shehu-Xhilaga M; Hill M; Marshall JA; Kappes J; Crowe SM; Mak J
J Virol; 2002 May; 76(9):4331-40. PubMed ID: 11932399
[TBL] [Abstract][Full Text] [Related]
57. Crosslink analysis of N-terminal, C-terminal, and N/B determining regions of the Moloney murine leukemia virus capsid protein.
McDermott J; Karanjia S; Love Z; Barklis E
Virology; 2000 Mar; 269(1):190-200. PubMed ID: 10725211
[TBL] [Abstract][Full Text] [Related]
58. Expression of a murine leukemia virus Gag-Escherichia coli RNase HI fusion polyprotein significantly inhibits virus spread.
VanBrocklin M; Ferris AL; Hughes SH; Federspiel MJ
J Virol; 1997 Apr; 71(4):3312-8. PubMed ID: 9060701
[TBL] [Abstract][Full Text] [Related]
59. Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein.
Burniston MT; Cimarelli A; Colgan J; Curtis SP; Luban J
J Virol; 1999 Oct; 73(10):8527-40. PubMed ID: 10482606
[TBL] [Abstract][Full Text] [Related]
60. HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles.
Douaisi M; Dussart S; Courcoul M; Bessou G; Vigne R; Decroly E
Biochem Biophys Res Commun; 2004 Aug; 321(3):566-73. PubMed ID: 15358144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
